• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Arvinas Inc (NQ: ARVN )

    31.90 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EDT, Apr 29, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 0
    Open 31.90
    Bid (Size) 12.76 (2)
    Ask (Size) 39.00 (10)
    Prev. Close 31.90
    Today's Range 31.90 - 31.90
    52wk Range 13.57 - 53.08
    Shares Outstanding 68,000,000
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Arvinas Appoints Randy Teel, Ph.D., as Chief Business Officer
    From Arvinas Inc.
    Via GlobeNewswire
    Biotech Stocks Heat As Arvinas Scores Novartis Licensing Pact, Janux Reportedly Explores Options
    Novartis snagged a licensing deal with Arvinas worth up to $1.16 billion, while Janux is said to be exploring its options. 
    Via Investor's Business Daily

    Performance

    YTD
    -23.13%
    -23.13%
    1 Month
    -21.04%
    -21.04%
    3 Month
    -19.32%
    -19.32%
    6 Month
    +111.54%
    +111.54%
    1 Year
    +17.97%
    +17.97%

    More News

    Read More
    Arvinas Enters into a Transaction with Novartis, including a Global License Agreement for the Development and Commercialization of PROTAC® Androgen Receptor (AR) Protein Degrader ARV-766 for the Treatment of Prostate Cancer
    From Arvinas Inc.
    Via GlobeNewswire
    Navigating 7 Analyst Ratings For Arvinas
    Via Benzinga
    Arvinas: Q4 Earnings Insights
    Via Benzinga
    Arvinas Inc. (NASDAQ: ARVN) Climbs to New 52-Week High
    Via Investor Brand Network
    Arvinas Appoints Noah Berkowitz, M.D., Ph.D., as Chief Medical Officer
    From Arvinas Inc.
    Via GlobeNewswire
    Arvinas to Participate in Upcoming Investor Conferences
    From Arvinas Inc.
    Via GlobeNewswire
    Cooper Companies Reports Upbeat Results, Joins Dell, NetApp, Tidewater And Other Big Stocks Moving Higher On Friday
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Forecasting The Future: 6 Analyst Projections For Arvinas
    Via Benzinga
    Expert Outlook: Arvinas Through The Eyes Of 9 Analysts
    Via Benzinga
    Why Zscaler Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
    Via Benzinga
    Arvinas Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
    From Arvinas Inc.
    Via GlobeNewswire
    Arvinas Announces Chief Financial Officer Transition
    From Arvinas Inc.
    Via GlobeNewswire
    Arvinas Announces First-in-Human Dosing of ARV-102, an Investigational PROTAC® Protein Degrader for Neurodegenerative Disease
    From Arvinas Inc.
    Via GlobeNewswire
    Carrick Therapeutics Announces First Patient Dosed in Phase 1b/2 Clinical Trial of Samuraciclib in Combination with Vepdegestrant in Patients with Advanced Breast Cancer
    From CARRICK THERAPEUTICS LIMITED
    Via GlobeNewswire
    SPS Commerce Posts Upbeat Results, Joins Masonite International, Impinj And Other Big Stocks Moving Higher On Friday
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Arvinas and Pfizer’s Vepdegestrant (ARV-471) Receives FDA Fast Track Designation for the Treatment of Patients with ER+/HER2- Metastatic Breast Cancer
    From Arvinas Inc.
    Via GlobeNewswire
    Arvinas to Present at 6th Annual Guggenheim Biotechnology Conference
    From Arvinas Inc.
    Via GlobeNewswire
    Eaton Posts Strong Results, Joins Ferrari, Boot Barn And Other Big Stocks Moving Higher On Thursday
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Arvinas Appoints Jared Freedberg as General Counsel
    From Arvinas Inc.
    Via GlobeNewswire
    Why Comtech Telecommunications Shares Are Trading Lower By Over 16%? Here Are Other Stocks Moving In Friday's Mid-Day Session
    Via Benzinga
    Torrid Reports Upbeat Results, Joins MBIA, Virco Mfg. And Other Big Stocks Moving Higher On Friday
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Why AeroVironment Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Intraday Session
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.